Intel jumps 10% as Google taps it for 3M chips. Nvidia also considers Intel, boosting valuation.
Tango Therapeutics' pancreatic cancer combo hits 92% ORR, fueling a massive surge. Investors eye high returns, but clinical trial risks remain.
Marvell Technology (MRVL) jumps on S&P 500 news, boosting tech hardware returns. Dow gains on geopolitical whispers.
AI stocks' blistering rally turns ugly; Korean market halts amid global chaos. Traders eye valuation risks.
SpaceX IPO looms: High valuation, retail investors beware. Cramer watches market movers.
SpaceX valuation hits $1.75T! Traders eye IPO, but is it worth the risk?
Obesity drug maker plunges 25% on safety data; investors weigh potential returns vs. risks.
Sponsored
Must Read